Trial in progress: Venetoclax in combination with ASTX727, an all-oral therapy for chronic myelomonocytic leukemia and other MDS/MPN with excess blasts (VICTORY MDS/MPN): A randomized, phase 2 trial Meeting Abstract


Authors: Shallis, R. M.; Blaha, O.; Halene, S.; Mendez, L.; Podoltsev, N. A.; Caldwell, A.; Bewersdorf, J. P.; Little, R. F.; Piekarz, R.; Patnaik, M. M.; Gore, S. D.; Zeidan, A. M.
Abstract Title: Trial in progress: Venetoclax in combination with ASTX727, an all-oral therapy for chronic myelomonocytic leukemia and other MDS/MPN with excess blasts (VICTORY MDS/MPN): A randomized, phase 2 trial
Meeting Title: 65th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 142
Issue: Suppl. 1
Meeting Dates: 2023 Dec 9-12
Meeting Location: San Deigo, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2023-11-02
Start Page: 3252
Language: English
ACCESSION: WOS:001159740303115
DOI: 10.1182/blood-2023-182814
PROVIDER: wos
Notes: Meeting Abstract -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors